Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease.

Front Neurol · 2023 · PMC10337130 · PMID 37448753

Europe PMC DOI

hedged sentences

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

showed a trendp = 0.051so close (0.05 < p ≤ 0.1)

Visual analysis Per-patient analysis showed a trend for a difference between Phases 1 and 2–3 in PET metabolism, which was more prominent in Phases 2–3 ( p = 0.051).

also in 53,322 other papers

a positive trendno p-value reported

Both of those regions showed a positive trend between the severity of hypometabolism and the phase of the disease.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.